{"id":"oral-captopril","safety":{"commonSideEffects":[{"rate":"10-20","effect":"Dry cough"},{"rate":"5-10","effect":"Dizziness"},{"rate":"2-5","effect":"Hyperkalemia"},{"rate":"0.1-0.5","effect":"Angioedema"},{"rate":"5-10","effect":"Hypotension"},{"rate":"2-5","effect":"Taste disturbance"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Captopril is an ACE inhibitor that blocks the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor. By reducing angiotensin II levels, the drug causes vasodilation, decreases peripheral vascular resistance, and reduces aldosterone secretion, leading to lower blood pressure and reduced cardiac workload. This mechanism also provides cardioprotective and renoprotective effects.","oneSentence":"Captopril inhibits angiotensin-converting enzyme (ACE), reducing the formation of angiotensin II and lowering blood pressure.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:58:40.785Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypertension"},{"name":"Heart failure"},{"name":"Post-myocardial infarction left ventricular dysfunction"},{"name":"Diabetic nephropathy"}]},"trialDetails":[{"nctId":"NCT07272486","phase":"NA","title":"The Use of Virtual Reality and Music Therapy for Hypertensive Urgency","status":"COMPLETED","sponsor":"Ankara City Hospital Bilkent","startDate":"2024-08-01","conditions":"Hypertensive Urgency, Primary Hypertension","enrollment":130},{"nctId":"NCT06190158","phase":"EARLY_PHASE1","title":"Subclinical Primary Aldosteronism in Diabetes At-Risk for Kidney Disease","status":"RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2024-05-15","conditions":"Type 2 Diabetes, Chronic Kidney Diseases","enrollment":125},{"nctId":"NCT05442463","phase":"","title":"Hormone Therapy and Angiotensin-Dependent Arterial and Renal Vasoconstriction in Humans","status":"RECRUITING","sponsor":"University of Calgary","startDate":"2020-11-30","conditions":"Hormone Therapy","enrollment":200},{"nctId":"NCT06853951","phase":"PHASE3","title":"Cardioprotection on Chemotherapy-Induced Cardiotoxicity","status":"RECRUITING","sponsor":"Ain Shams University","startDate":"2023-07-18","conditions":"Cardiotoxicity","enrollment":30},{"nctId":"NCT05498675","phase":"","title":"Effect of Sacubitril/Valsartan on Cardiac Function in Hypertensive Patients Stratified by BMI: A Real World Study","status":"RECRUITING","sponsor":"Beijing Friendship Hospital","startDate":"2021-09-01","conditions":"Sacubitril/Valsartan, Hypertension, Obesity","enrollment":180},{"nctId":"NCT05959863","phase":"","title":"Primary Aldosteronism LC-MS/MS-specific Cutoffs","status":"COMPLETED","sponsor":"Chongqing Medical University","startDate":"2023-06-01","conditions":"Primary Aldosteronism","enrollment":396},{"nctId":"NCT06500000","phase":"","title":"The Plasma Metabolomics Profiling of Primary Aldosteronism","status":"COMPLETED","sponsor":"Third Military Medical University","startDate":"2022-08-15","conditions":"Primary Aldosteronism, Essential Hypertension, Idiopathic Aldosteronism","enrollment":95},{"nctId":"NCT06417320","phase":"PHASE4","title":"Effect of Sodium-glucose Cotransporter-2 Inhibitors (SGLT-2i) on Proteinuria in Nephrotic Children Older Than 10 Years","status":"RECRUITING","sponsor":"Mansoura University","startDate":"2023-06-01","conditions":"Nephrotic Syndrome in Children","enrollment":60},{"nctId":"NCT06253429","phase":"PHASE3","title":"Alpha-lipoic Acid in Diabetic Nephropathy","status":"UNKNOWN","sponsor":"Ain Shams University","startDate":"2023-01-01","conditions":"Type 1 Diabetes","enrollment":30},{"nctId":"NCT06141200","phase":"PHASE3","title":"NW Roselle in Grade 1 Essential Hypertension: Phase III Clinical Trial","status":"UNKNOWN","sponsor":"Natural Wellness Egypt","startDate":"2024-03","conditions":"Essential Hypertension","enrollment":286},{"nctId":"NCT04629651","phase":"PHASE1, PHASE2","title":"Captopril Use on the Degree of Marrow Fibrosis in Bone Marrow Fibrosis/Myeloproliferative Neoplasms","status":"WITHDRAWN","sponsor":"Case Comprehensive Cancer Center","startDate":"2024-04","conditions":"Bone Marrow Fibrosis, Myeloproliferative Neoplasm","enrollment":""},{"nctId":"NCT06039592","phase":"","title":"Study of Innovative Drug Strategies in Improving Left Ventricular Function After Mitral Repair","status":"UNKNOWN","sponsor":"China National Center for Cardiovascular Diseases","startDate":"2022-04-01","conditions":"Congenital Mitral Insufficiency","enrollment":164},{"nctId":"NCT06039540","phase":"","title":"Study of Drug Therapy for Pediatric Heart Failure","status":"UNKNOWN","sponsor":"China National Center for Cardiovascular Diseases","startDate":"2022-01-01","conditions":"Heart Failure Congenital","enrollment":200},{"nctId":"NCT06037434","phase":"","title":"Study of Innovative Drug Treatment Therapy for Pediatric Mitral Regurgitation","status":"UNKNOWN","sponsor":"China National Center for Cardiovascular Diseases","startDate":"2022-04-01","conditions":"Congenital Mitral Insufficiency","enrollment":122},{"nctId":"NCT04878315","phase":"PHASE1","title":"Bioequivalence Study Between Capoten Versus Captopril Reference Product in Healthy Adult Participants Under Fasting Conditions","status":"WITHDRAWN","sponsor":"GlaxoSmithKline","startDate":"2022-02-13","conditions":"Healthy Volunteers","enrollment":""},{"nctId":"NCT04964050","phase":"PHASE1","title":"A Bioequivalence Study Between Capozide Versus ACE-Hemmer-ratiopharm in Healthy Adult Participants Under Fasting Conditions","status":"WITHDRAWN","sponsor":"GlaxoSmithKline","startDate":"2022-04-21","conditions":"Healthy Volunteers","enrollment":""},{"nctId":"NCT04193137","phase":"","title":"Comparison of Three Confirmatory Tests in the Diagnosis of Primary Aldosteronism","status":"COMPLETED","sponsor":"Chongqing Medical University","startDate":"2019-11-30","conditions":"Primary Aldosteronism","enrollment":200},{"nctId":"NCT04467931","phase":"","title":"ACEI or ARB and COVID-19 Severity and Mortality in US Veterans","status":"COMPLETED","sponsor":"University of Utah","startDate":"2020-01-19","conditions":"Hypertension, COVID","enrollment":22213},{"nctId":"NCT03500120","phase":"","title":"Diagnostic Accuracy of Seated Saline Suppression Test for Primary Aldosteronism","status":"COMPLETED","sponsor":"Chongqing Medical University","startDate":"2017-09-01","conditions":"Primary Aldosteronism","enrollment":200},{"nctId":"NCT04485845","phase":"PHASE4","title":"Metformin Versus Vildagliptin in Reducing Risk of Metabolic Syndrome Complications Progression","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2019-11-01","conditions":"Metabolic Syndrome, Diabete Type 2, Kidney Insufficiency","enrollment":39},{"nctId":"NCT04371874","phase":"NA","title":"The Standardized Management of Hypertension in Rural Shaanxi","status":"COMPLETED","sponsor":"First Affiliated Hospital Xi'an Jiaotong University","startDate":"2014-01","conditions":"Hypertension","enrollment":1210},{"nctId":"NCT04288700","phase":"PHASE4","title":"Evaluation of the Efficacy of Captopril Versus Propranolol and Timolol as a Treatment of Infantile Capillary Hemangioma","status":"UNKNOWN","sponsor":"Ain Shams University","startDate":"2019-10-01","conditions":"Infantile Hemangioma","enrollment":100},{"nctId":"NCT03370705","phase":"PHASE3","title":"Endothelial Function Evaluation in Patients With PAOD Treated With Sulodexide + Conventional Treatment (CT) Vs CT Alone","status":"UNKNOWN","sponsor":"Alfa Wassermann Tunisia","startDate":"2019-01-31","conditions":"Peripheral Arterial Obstructive Disease","enrollment":156},{"nctId":"NCT01271478","phase":"PHASE4","title":"Use of Telmisartan and Captopril in Inflammation of Hemodialysis Patients","status":"COMPLETED","sponsor":"Coordinación de Investigación en Salud, Mexico","startDate":"2009-08","conditions":"Inflammation, End-stage Renal Disease","enrollment":60},{"nctId":"NCT01292694","phase":"PHASE1","title":"Contribution of Angiotensin II to Supine Hypertension in Autonomic Failure","status":"TERMINATED","sponsor":"Vanderbilt University","startDate":"2011-03","conditions":"Hypertension, Pure Autonomic Failure, Multiple System Atrophy","enrollment":12},{"nctId":"NCT03147092","phase":"EARLY_PHASE1","title":"Matão Controlling Hypertension (MatCH Study): Rationale and Design","status":"UNKNOWN","sponsor":"Centro Neurológico de Pesquisa e Reabiitação, Brazil","startDate":"2018-02-01","conditions":"Hypertension, Blood Pressure","enrollment":15000},{"nctId":"NCT01761916","phase":"PHASE4","title":"Clonidine Versus Captopril for Treatment of Postpartum Very High Blood Pressure","status":"COMPLETED","sponsor":"Instituto Materno Infantil Prof. Fernando Figueira","startDate":"2013-01","conditions":"Preeclampsia","enrollment":90},{"nctId":"NCT00660309","phase":"PHASE4","title":"A Clinical Study to Evaluate Renal Hemodynamic Responses to Aliskiren in Patients With Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"Novartis","startDate":"2008-04","conditions":"Type 2 Diabetes Mellitus","enrollment":45},{"nctId":"NCT00935805","phase":"","title":"Glycemic And Blood Pressure Control In Type 2 Diabetes, In A Primary Care Unit: A Staged Management Strategy","status":"UNKNOWN","sponsor":"Hospital de Clinicas de Porto Alegre","startDate":"2006-07","conditions":"Diabetes Mellitus, Arterial Hypertension","enrollment":124},{"nctId":"NCT00518765","phase":"PHASE3","title":"Hemodynamic Effects of Aliskiren Compared to Captopril on the Kidney in Healthy Volunteers on a Low- and High- Sodium Diet","status":"COMPLETED","sponsor":"Novartis","startDate":"2005-10","conditions":"Hypertension","enrollment":32}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Oral Captopril","genericName":"Oral Captopril","companyName":"Ain Shams University","companyId":"ain-shams-university","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Captopril inhibits angiotensin-converting enzyme (ACE), reducing the formation of angiotensin II and lowering blood pressure. Used for Hypertension, Heart failure, Post-myocardial infarction left ventricular dysfunction.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}